HCPCS Level II
G9673
I intend to report the cardiovascular prevention measures group
- NDC crosswalk
- None in the loaded CMS ASP file
Codes near G9673
These sit next to G9673 in the CMS Level II file. All G codes
- G9667Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)
- G9669I intend to report the multiple chronic conditions measures group
- G9670All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient
- G9671I intend to report the diabetic retinopathy measures group
- G9672All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient
- G9674Patients with clinical ascvd diagnosis
- G9675Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl
- G9676Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period
- G9677All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient
- G9678Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement